[Recommendations for clinical practice. Therapeutic choices for rectal cancer. How should neoadjuvant therapies be chosen?].
Portier
Guillaume
G
portier.g@chu-toulouse.fr
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D003657:Decision Making; D003952:Diagnostic Imaging; D006801:Humans; D020360:Neoadjuvant Therapy / Q000592:standards*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000473:pathology / Q000628:therapy*; D016019:Survival Analysis
D000970:Antineoplastic Agents